Short Interest in Talphera, Inc. (NASDAQ:TLPH) Drops By 16.9%

Talphera, Inc. (NASDAQ:TLPH) saw a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 139,800 shares, a decrease of 16.9% from the May 31st total of 168,300 shares. Based on an average daily volume of 69,900 shares, the days-to-cover ratio is presently 2.0 days. Approximately 0.8% of the shares of the company are sold short.

Talphera Stock Performance

NASDAQ:TLPH opened at $0.89 on Monday. Talphera has a one year low of $0.43 and a one year high of $1.61. The stock’s 50 day simple moving average is $1.00.

Talphera (NASDAQ:TLPH) last released its quarterly earnings results on Tuesday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.12. On average, analysts expect that Talphera will post -0.84 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Maxim Group began coverage on Talphera in a research report on Monday, May 6th. They issued a “buy” rating and a $3.00 target price on the stock. HC Wainwright restated a “buy” rating and set a $6.00 price objective on shares of Talphera in a research report on Wednesday, May 15th.

About Talphera

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.